P0039 Beyond first progression: PFS2 as a strong surrogate of overall survival in real-world apalutamide-treated mHSPC patients

European Urology 2026

View at publisher
Authors: A. Bonet, J. Gomez-Rivas, Sutil R. Sopena, Espinos E. Linares, Lopez J.C. Garcia, Breijo S. Martinez, Esteban M. Dominguez, Pedro de Pablos‐Rodríguez, Rodríguez J. Munoz, Cascales A. Guijarro, Cortes M. Beamud, J.M. De La Morena Gallego
+1 more González Ríos
DOI: 10.1016/s0302-2838(26)00956-5
Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Renal cell carcinoma treatment

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S2
Publication date
13 February 2026
Language
EN